Austrian pharma company alleges arbitral fraud

An Austrian pharmaceuticals company has asked a US court to grant discovery to support criminal allegations that its Taiwanese partner has made fraudulent statements in two ICC arbitrations arising from a multibillion-euro dispute over a blood cancer drug.

Unlock unlimited access to all Global Arbitration Review content